LBTSF - Eli Lilly eczema drug shows robust efficacy in people of color March, 11 2024 05:53 AM Almirall Sa Ord 2024-03-11 05:53:32 ET Eli Lilly ( NYSE: LLY ) on Sunday reported robust efficacy data from a study for its atopic dermatitis drug, lebrikizumab.... For further details see: Eli Lilly eczema drug shows robust efficacy in people of color